Identifying speech and neurodevelopmental conditions like autism or ADHD takes a longer time. Limited access to specialists and fragmented processes make early intervention difficult. Gabify is trying to address this with an AI-led platform that combines screening and therapy management.
Founded in 2023, is building an AI-based platform for early screening and therapy management of speech and neurodevelopmental disorders. The system combines voice and vision-based AI to analyse speech patterns, facial expressions, eye movement, and behavioural indicators across more than 189 clinically validated parameters aligned with global diagnostic frameworks.
The platform also uses a human-in-the-loop approach, where clinical experts review AI-generated outputs to ensure accuracy and reliability in assessments. The company said its system can reduce assessment time by up to 70 percent, allowing clinicians to serve more patients while maintaining clinical standards.
Gabify’s platform has already been tested across more than 35 preschool and daycare centres in India during its private beta phase.
Also Read: AI in Healthcare: Applications, Benefits, Use Cases, and Future Trends
